Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $439.7000 (3.11%) ($415.0500 - $465.0000) on Mon. Apr. 4, 2011. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.31% (three month average) | RSI | 78 | Latest Price | $439.7000(3.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 8.7% a day on average for past five trading days. | Weekly Trend | CAPR advances 14.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(4%) IWM(3%) XOP(3%) EWI(2%) EWP(2%) | Factors Impacting CAPR price | CAPR will decline at least -3.155% in a week (0% probabilities). REMX(-1%) IGOV(-1%) EWY(-1%) XLU(0%) XLP(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.155% (StdDev 6.31%) | Hourly BBV | 0 () | Intraday Trend | -5.4% | | | |
|
5 Day Moving Average | $375.23(17.18%) | 10 Day Moving Average | $338.92(29.74%) | 20 Day Moving Average | $320.87(37.03%) | To recent high | 0% | To recent low | 72.4% | Market Cap | $8.661b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |